retatrutide clinical trials sign up How to Get in 2026 retatrutide clinical trial availability Retatrutide

In addition to appetite control, GLP-1 injections can improve insulin sensitivity and help regulate blood sugar levels, which is particularly beneficial for people with obesity or those at risk of developing type 2 diabetes

GLP-1 RAs can slow how your body absorbs other drugs

The LEAN-PREP trial (NCT06885736) is enrolling [11]

Discontinuation Rates Discontinuation rates due to adverse events in the Phase 2 trial were dose-dependent, ranging from approximately 6% in the 1 mg arm to 16% in the 12 mg arm

Tresiba extends well beyond that window, which means small variations in injection timing do not cause the dramatic blood sugar swings that can occur with shorter-duration basal insulins